A detailed history of Gsa Capital Partners LLP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 173,744 shares of DSGN stock, worth $1.08 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
173,744
Previous 209,953 17.25%
Holding current value
$1.08 Million
Previous $703,000 33.0%
% of portfolio
0.07%
Previous 0.05%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$3.19 - $5.88 $115,506 - $212,908
-36,209 Reduced 17.25%
173,744 $935,000
Q2 2024

Aug 15, 2024

SELL
$3.23 - $4.77 $20,652 - $30,499
-6,394 Reduced 2.96%
209,953 $703,000
Q1 2024

May 03, 2024

BUY
$2.27 - $4.03 $327,004 - $580,541
144,055 Added 199.27%
216,347 $871,000
Q4 2023

Feb 16, 2024

BUY
$1.99 - $2.76 $57,134 - $79,242
28,711 Added 65.88%
72,292 $191,000
Q3 2023

Nov 15, 2023

SELL
$2.05 - $8.14 $398,968 - $1.58 Million
-194,619 Reduced 81.7%
43,581 $102,000
Q2 2023

Aug 14, 2023

BUY
$4.99 - $7.64 $700,097 - $1.07 Million
140,300 Added 143.31%
238,200 $1.5 Million
Q1 2023

May 12, 2023

BUY
$5.5 - $9.77 $463,545 - $823,425
84,281 Added 618.85%
97,900 $564,000
Q4 2022

Feb 13, 2023

BUY
$7.86 - $17.2 $107,045 - $234,246
13,619 New
13,619 $140,000

Others Institutions Holding DSGN

About Design Therapeutics, Inc.


  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $347M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.